Genetically Modified Cell Transplantation Through Macroencapsulated Spheroids with Scaffolds to Treat Fabry Disease

Cell transplantation is expected to be another strategy to treat lysosomal diseases, having several advantages compared to enzyme replacement therapy, such as continuous enzyme secretion and one-time treatment to cure diseases. However, cell transplantation for lysosomal diseases holds issues to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Kami, Daisuke, Suzuki, Yosuke, Yamanami, Masashi, Tsukimura, Takahiro, Togawa, Tadayasu, Sakuraba, Hitoshi, Gojo, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842475/
https://www.ncbi.nlm.nih.gov/pubmed/34931534
http://dx.doi.org/10.1177/09636897211060269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842475/
https://www.ncbi.nlm.nih.gov/pubmed/34931534
http://dx.doi.org/10.1177/09636897211060269

Ejemplares similares